Extensive antigenic diversification of foot-and-mouth disease virus by amino acid substitutions outside the major antigenic site

References

1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2.9 A resolution. Nature, London 337:709–715
   [Google Scholar]
2. Alonso Fernandez A., Casas Olascoaga R., Augé de Mello P., Fernandez G., Mazzuca G. 1986; The evolution of the FMDV virus C₃ Argentina in the field. Report of the Session of the Research Group of the Standing Technical Committee of the European Commission for the Control of Foot-and-Mouth Disease pp 42–48 Lanham, Maryland: Beman-Unipub;
   [Google Scholar]
3. Bergmann I. E., Tiraboschi B., Mazzuca G., Fernandez E., Michailoff C. A., Scodeller E. A., La Torre J. L. 1988; Serological and biochemical analysis of foot-and-mouth disease virus (serotype C₃) isolated in Argentina between 1981 and 1986. Vaccine 6:245–252
   [Google Scholar]
4. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A., Rowlands D. J, Brown F. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature, London 298:30–33
   [Google Scholar]
5. Bolwell C., Clarke B. E., Parry N. R., Ouldridge E. J., Brown F., Rowlands D. J. 1989; Epitope mapping of foot-and-mouth disease virus with neutralizing monoclonal antibodies. Journal of General Virology 70:59–68
   [Google Scholar]
6. Bolwell C., Parry N. R., Rowlands D. J. 1992; Comparison between in vitro neutralization titres and in vivo protection against homologous and heterologous challenge induced by vaccines prepared from two serologically distinct variants of foot-and-mouth disease virus, serotype A22. Journal of General Virology 73:727–731
   [Google Scholar]
7. Clarke B. E., Carroll A. R., Rowlands D. J., Nicholson B. H., Houghten R. A., Lerner R. A., Brown F. 1983; Synthetic peptides mimic subtype specificity of foot-and-mouth disease virus. FEBS Letters 157:261–264
   [Google Scholar]
8. Doel T. R., Gale C., Do Amaral C. M. C. F., Mulcahy G., Di Marchi R. 1990; Heterotypic protection induced by synthetic peptides corresponding to three serotypes of foot-and-mouth disease virus. Journal of Virology 64:2260–2264
   [Google Scholar]
9. Domingo E., Davila M., Ortin J. 1980; Nucleotide sequence heterogeneity of the RNA from a natural population of foot-and-mouth disease virus. Gene 11:333–346
   [Google Scholar]
10. Domingo E., Mateu M. G., Martínez M. A., Dopazo J., Moya A., Sobrino F. 1990; Genetic variability and antigenic diversity of foot-and-mouth disease virus. In Applied Virology Research: Virus Variability, Epidemiology and Control vol 2 pp. 233–266 Edited by Kurstak E., Marusyk R. G., Murphy F. A., Van Regenmortel M. H. V. New York: Plenum Press;
    [Google Scholar]
11. Domingo E., Escarmis C., Martinez M. A., Martínez-Salas E., Mateu M. G. 1992; Foot-and-mouth disease virus populations are quasispecies. Current Topics in Microbiology and Immunology 176:33–47
    [Google Scholar]
12. Giavedoni L. D., Kaplan G., Marcovecchio F., Piccone M. E., Palma E. L. 1991; Protection conferred by TrpE fusion proteins containing portions of the C-terminal region of capsid protein VP 1 of foot-and-mouth disease virus. Journal of General Virology 72:967–971
    [Google Scholar]
13. Kitson J. D. A., McCahon D., Belsham G. J. 1990; Sequence analysis of monoclonal antibody resistant mutants of type O foot-and-mouth disease virus: evidence for the involvement of the three surface exposed capsid proteins in four antigenic sites. Virology 179:26–34
    [Google Scholar]
14. Kitson J. D. A., Burke K. L., Pullen L. A., Belsham G. J., Almond J. W. 1991; Chimeric polioviruses that include sequences derived from two independent antigenic sites of foot-and-mouth disease virus (FMDV) induce neutralizing antibodies against FMDV in guinea pigs. Journal of Virology 65:3068–3075
    [Google Scholar]
15. Martínez M. A., Carrillo C., Plana J., Mascarella R., Bergada J., Palma E. L., Domingo E., Sobrino F. 1988; Genetic and immunogenic variations among closely related isolates of foot-and-mouth disease virus. Gene 62:75–84
    [Google Scholar]
16. Martínez M. A., Hernandez J., Piccone M. E., Palma E. L., Domingo E., Knowles N. J., Mateu M. G. 1991; Two mechanisms of antigenic diversification of foot-and-mouth disease virus. Virology 184:695–706
    [Google Scholar]
17. Martínez M. A., Dopazo J., Hernandez J., Mateu M. G., Sobrino F., Domingo E., Knowles N. J. 1992; Evolution of the capsid protein genes of foot-and-mouth disease virus: antigenic variation without accumulation of amino acid substitutions over six decades. Journal of Virology 66:3557–3565
    [Google Scholar]
18. Mateu M. G., Rocha E., Vicente O., Vayreda F., Navalpotro C., Andreu A., Pedroso E., Giralt E., Enjuanes L., Domingo E. 1987; Reactivity with monoclonal antibodies of viruses from an episode of foot-and-mouth disease. Virus Research 8:261–274
    [Google Scholar]
19. Mateu M. G., Da Silva J. L., Rocha E., De Brum D. L., Alonso A., Enjuanes L., Domingo E., Barahona H. 1988; Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C. Virology 167:113–124
    [Google Scholar]
20. Mateu M. G., Martínez M. A., Rocha E., Andreu D., Parejo J., Giralt E., Sobrino F., Domingo E. 1989; Implications of a quasispecies genome structure: effect of frequent, naturally occurring amino acid substitutions on the antigenicity of foot-and-mouth disease virus. Proceedings of the National Academy of Sciences, U.S.A. 86:5883–5887
    [Google Scholar]
21. Mateu M. G., Martínez M. A., Capucci L., Andreu D., Giralt E., Sobrino F., Brocchi E., Domingo E. 1990; A single amino acid substitution affects multiple overlapping epitopes in the major antigenic site of foot-and-mouth disease virus of serotype C. Journal of General Virology 71:629–637
    [Google Scholar]
22. Mateu M. G., Andreu D., Carreno C., Roig X., Cairo J. J., Camarero J. A., Giralt E., Domingo E. 1992; Non-additive effects of multiple amino acid substitutions on antigen-antibody recognition. European Journal of Immunology 22:1385–1389
    [Google Scholar]
23. Minor P. D. 1990; Antigenic structure of picomaviruses. Current Topics in Microbiology and Immunology 161:121–154
    [Google Scholar]
24. Ouldridge E. J., Parry N. R., Barnett P. V., Bolwell C., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1986; Comparison of the structures of the major antigenic sites of foot-and-mouth disease viruses of two different serotypes. In Vaccines 86: New Approaches to Immunization pp. 45–50 Edited by Brown F., Chanock R. M., Lerner R. A. New York: Cold Spring Harbor Laboratory;
    [Google Scholar]
25. Parry N. R., Barnett P. V., Ouldridge E. J., Rowlands D. J., Brown F. 1989a; Neutralizing epitopes of type O foot-and-mouth disease virus. II. Mapping three conformational sites with synthetic peptide reagents. Journal of General Virology 70:1493–1503
    [Google Scholar]
26. Parry N. R., Ouldridge E. J., Barnett P. V., Clarke B. E., Francis M. J., Fox J. D., Rowlands D. J., Brown F. 1989b; Serological prospects for peptide vaccines against foot-and-mouth disease virus. Journal of General Virology 70:2919–2930
    [Google Scholar]
27. Parry N. R., Fox G., Rowlands D. J., Brown F., Fry E., Acharya R., Logan D., Stuart D. 1990; Structural and serological evidence for a novel mechanism of antigenic variation in foot-and-mouth disease virus. Nature, London 347:569–572
    [Google Scholar]
28. Pereira H. G. 1977; Subtyping of foot-and-mouth disease virus. In Developments in Biological Standardization vol 35 pp. 167–174 Edited by Mackowiak C., Regamey R. H. Basel: S. Karger;
    [Google Scholar]
29. Pfaff E., Mussgay M., Böhm H. O., Schulz G. E., Schaller H. 1982; Antibodies against a preselected peptide recognize and neutralize foot-and-mouth disease virus. EMBO Journal 1:869–874
    [Google Scholar]
30. Piccone M. E. 1989 Caracterizacion molecular de cepas del virus de la fiebre aftosa actuantes en Argentina PhD. thesis Universidad de Buenos Aires;
    [Google Scholar]
31. Piccone M. E., Kaplan G., Giavedoni L., Domingo E., Palma E. L. 1988; VP1 of serotype C foot-and-mouth disease virus: long-term conservation of sequences. Journal of Virology 62:1469–1473
    [Google Scholar]
32. Rowlands D. J., Clarke B. E., Carroll A. R., Brown F., Nicholson B. H., Bittle J. L., Houghten R. A., Lerner R. A. 1983; Chemical basis of antigenic variation in foot-and-mouth disease virus. Nature, London 306:694–697
    [Google Scholar]
33. Sobrino F., Martínez M. A., Carrillo C., Beck E. 1989; Antigenic variation of foot-and-mouth disease virus of serotype C during propagation in the field is mainly restricted to only one structural protein (VP1). Virus Research 14:273–280
    [Google Scholar]
34. Strohmaier K., Franze R., Adam K.-H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
35. Thomas A. M., Woortmeijer R. J., Puijk W., Barteling S. J. 1988; Antigenic sites of foot-and-mouth disease virus type A10. Journal of Virology 62:2782–2789
    [Google Scholar]
36. Xie Q.-C., McCahon D., Crowther J. R., Belsham G. J., McCullough K. C. 1987; Neutralization of foot-and-mouth disease virus can be mediated through any of at least three separate antigenic sites. Journal of General Virology 681637–1647
    [Google Scholar]